Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial

Published:2022-09 Issue:9 Volume:10 Page:623-633
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Inagaki Nobuya,Takeuchi Masakazu,Oura Tomonori,Imaoka Takeshi,Seino Yutaka

Funder

Eli Lilly Japan

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference29 articles.

1. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas;Seino;J Diabetes Investig,2013

2. GIP and GLP-1, the two incretin hormones: Similarities and differences;Seino;J Diabetes Investig,2010

3. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art;Nauck;Mol Metab,2021

4. GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice;Samms;J Clin Invest,2021

5. Plasma insulin response to oral and intravenous glucose administration;Elrick;J Clin Endocrinol Metab,1964

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation;International Journal of Molecular Sciences;2024-09-08

2. The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity: A Systematic Review of Randomized, Controlled Studies;Diseases;2024-09-05

3. Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice;Endocrine;2024-08-30

4. Tirzepatide outcompetes long-acting insulin in managing type 2 diabetes: a meta-analysis of three phase 3 randomized controlled trials;International Journal of Obesity;2024-08-29

5. Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management;Expert Review of Endocrinology & Metabolism;2024-08-28